Esophageal Cancer Awareness Month: Treatment Advances and Tools for Maximizing Tolerability

This April, Oncology Data Advisor is raising awareness for Esophageal Cancer Awareness Month. In this interview, Oncology Data Advisor Editorial Board and Fellows Forum members Dr. Joseph Kalis, Dr. Matthew Hadfield, and Dr. Samuel Kareff discuss rising trends, treatment advances, and emerging management strategies for esophageal cancer, including the following:

• The rising rate of adenocarcinoma in the context of pre-existing esophageal dysplasia and Barrett esophagus

• Risk factors such as tobacco and alcohol

• The roles of healthy eating and smoking cessation in esophageal cancer prevention

• How the rise of immunotherapies such as pembrolizumab, nivolumab, and trastuzumab have changed practice

• This month’s approval of fam-trastuzumab deruxtecan-nxki for human epidermal growth factor receptor 2 (HER2)–positive solid tumors

• Lifestyle interventions such as following the Mediterranean diet and United States Preventive Services Task Force (USPSTF) exercise guidelines that can make maximize tolerability of therapy